Back to search

Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial

Data up to Jan 2025

Published2008
Citations93
References27
Clinical Trials (1)

Total Citations Per Year

Abstract

References (27)

1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

2002 • 1,778 citations

Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease

2006 • 1,697 citations

1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

2002 • 1,556 citations

Current Understanding of the Molecular Actions of Vitamin D

1998 • 1,259 citations

The Commonest Glomerulonephritis in the World: IgA Nephropathy

1987 • 873 citations

1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line.

2001 • 849 citations

Corticosteroids in IgA nephropathy: a randomised controlled trial

1999 • 494 citations

Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases

1997 • 468 citations

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

2005 • 371 citations

Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1998 • 248 citations

Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

1999 • 246 citations

IgACE

2007 • 240 citations

1,25-Dihydroxyvitamin D3decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat

2004 • 221 citations

Hong Kong Study Using Valsartan in IgA Nephropathy (HKVIN): A Double-Blind, Randomized, Placebo-Controlled Study

2006 • 197 citations

Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats

2007 • 196 citations

Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury

2000 • 179 citations

Prognostic indicators of IgA nephropathy in the Chinese—clinical and pathological perspectives

2002 • 168 citations

A Vitamin D Analog Ameliorates Glomerular Injury on Rat Glomerulonephritis

2001 • 138 citations

ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study

1994 • 120 citations

A SYNTHETIC ANALOGUE OF VITAMIN D3, 22-OXA-lα,25-DIHYDROXYVITAMIN D3IS A POTENT MODULATOR OF IN VIVO IMMUNOREGULATING ACTIVITY WITHOUT INDUCING HYPERCALCEMIA IN MICE

1989 • 106 citations

1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression

2005 • 102 citations

22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats

2002 • 79 citations

The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.

1998 • 74 citations

Outcome of IgA nephropathy in adults graded by chronic histological lesions

2000 • 68 citations

Vitamin D analogues

1998 • 62 citations

A Vitamin D Analog Regulates Mesangial Cell Smooth Muscle Phenotypes in a Transforming Growth Factor-β Type II Receptor-mediated Manner

1999 • 34 citations

Treating IgA Nephropathy

2001 • 20 citations

Cited By (0)

Loading...